THE INCIDENCE OF LOWER EXTREMITY AMPUTATION AND BONE RESECTION IN DIABETIC FOOT ULCER PATIENTS TREATED WITH A HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE

被引：0
|
作者：
Frykberg, R. G. [1 ]
Marston, W. A. [2 ]
Cardinal, M. [3 ]
机构：
[1] Phoenix VA Healthcare Syst, Phoenix, AZ USA
[2] UNC Dept Surg, Div Vasc Surg, Chapel Hill, NC USA
[3] Adv BioHealing, San Diego, CA USA
来源：
WOUND REPAIR AND REGENERATION | 2012年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [31] Human fibroblast-derived dermal substitute counteracts the growth inhibitory and senescence-inducing properties of chronic wound fluid
    Phillips, T
    Park, HY
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB243 - AB243
  • [32] The value of Doppler waveform analysis in predicting major lower extremity amputation among dialysis patients treated for diabetic foot ulcers
    Tsai, Chih-Yiu
    Chu, Sung-Yu
    Wen, Yu-Wen
    Hsu, Lung-An
    Chen, Chun-Chi
    Peng, Shih-Hui
    Huang, Chung-Huei
    Sun, Jui-Hung
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (02) : 181 - 188
  • [33] Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital
    Li, Xiang
    Xiao, Ting
    Wang, Yuzhen
    Gu, Hongbin
    Liu, Zhiguo
    Jiang, Yufeng
    Liu, Yanjun
    Lu, Zuqian
    Yang, Xiaopin
    Lan, Yin
    Xu, Zhangrong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (01) : 26 - 30
  • [34] HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (HFDS) INCREASES DERMAL ANTIOXIDANTS AND IMPROVES REEPITHELIALIZATION OF WOUNDED SKIN EXPLANTS FROM YOUNG AND AGED DONORS
    Moor, A. N.
    Young, C.
    Wilkins-Port, C.
    Gould, L. J.
    WOUND REPAIR AND REGENERATION, 2013, 21 (02) : A36 - A36
  • [35] Total contact casting combined with human fibroblast-derived dermal tissue in 15 DFU patients
    Kashefsky, H.
    Marston, W.
    JOURNAL OF WOUND CARE, 2012, 21 (05) : 236 - +
  • [36] DIFFERENTIATION OF A HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (HFDS*) AND CRYOPRESERVED HUMAN SKIN ALLOGRAFT (TS#) FOR PROPERTIES RELATED TO WOUND HEALING
    Wilkins-Port, C. E.
    Browning, C. S.
    Self, C.
    Hart, C. E.
    Young, C. S.
    WOUND REPAIR AND REGENERATION, 2014, 22 (02) : A67 - A67
  • [37] A meta-analysis of the relationship between foot local characteristics and major lower extremity amputation in diabetic foot patients
    Wang, Ning
    Yang, Bo-Hua
    Wang, Gang
    Gao, Yu
    Cao, Xin
    Zhang, Xiao-Fu
    Yan, Cheng-Cheng
    Lian, Xiao-Tong
    Liu, Bo-Hong
    Ju, Shang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (06) : 9091 - 9096
  • [38] Impact of multidisciplinary foot care team on outcome of diabetic foot ulcer in term of lower extremity amputation at a tertiary care unit in Karachi, Pakistan
    Riaz, Musarrat
    Miyan, Zahid
    Waris, Nazish
    Zaidi, Syed I. H.
    Tahir, Bilal
    Fawwad, Asher
    Basit, Abdul
    INTERNATIONAL WOUND JOURNAL, 2019, 16 (03) : 768 - 772
  • [39] EVALUATION OF DOSING EFFECTS OF A HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (DS) ON WOUND CLOSURE IN A FULL-THICKNESS DERMAL WOUND MODEL IN ATHYMIC RATS
    Young, C. S.
    Wilkins-Port, C. E.
    Self, C.
    Hart, C. E.
    WOUND REPAIR AND REGENERATION, 2012, 20 (02) : A48 - A48
  • [40] Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection
    Lipsky, Benjamin A.
    Weigelt, John A.
    Sun, Xiaowu
    Johannes, Richard S.
    Derby, Karen G.
    Tabak, Ying P.
    DIABETES CARE, 2011, 34 (08) : 1695 - 1700
12345